Thank you for Subscribing to Food Business Review Weekly Brief
Food Business Review | Monday, August 24, 2026
A gummy formula can look commercially sound on paper and still become difficult to manufacture at scale. High active loads may affect texture. Certain ingredients can complicate depositing or curing. Flavor masking may alter the eating experience. For supplement brands, these issues surface late, often after launch plans and packaging commitments are already underway.
Manufacturing selection should therefore begin with formulation depth rather than production capacity alone. A capable partner must understand how active ingredients behave inside a gummy matrix and how adjustments affect dose consistency, taste, appearance and shelf stability. The strongest development teams do more than accept a brief. They identify processing risks early and test workable alternatives while preserving the product concept without allowing technical constraints to dictate an inferior consumer experience.
Stay ahead of the industry with exclusive feature stories on the top companies, expert insights and the latest news delivered straight to your inbox. Subscribe today.
Production method also matters. Starch-based and starchless lines offer different advantages, and not every formula belongs on the same platform. Buyers should examine whether a manufacturer can match the process to the formulation instead of forcing every project through one line. This flexibility becomes especially important for brands moving into higher-dose products or sugar-free formats. A narrow production model can limit the formula before development has properly begun.
Quality systems deserve equal scrutiny, but certificates alone provide an incomplete view. Executives need to understand how a manufacturer controls raw material variation and documents release decisions. Equipment condition and staff experience affect whether those controls work in practice. Facilities serving dietary supplement and over-the-counter requirements may offer useful discipline, provided the manufacturer can clearly separate standards and customer expectations.
Geographic reach can reduce another common source of strain. Brands with distributed warehousing or international sales channels may face longer replenishment cycles when production is concentrated in one region. Multiple sites can shorten supply routes and create alternatives when capacity shifts, though only when technical knowledge travels between locations. Buyers should ask how formulas are transferred and how specifications remain aligned. Responsibility for the handoff from development into routine production should also be clear.
“TopGum Industries combines starch-based and starchless production with facilities positioned to support brands across North America and other international markets.”
Commercial flexibility is most valuable when it is backed by problem-solving discipline. Some manufacturers decline formulas once processing becomes inconvenient. Others continue development without a realistic path to repeatable output. The better partner knows when to reformulate and when to change the manufacturing method. It should also recognize when an ingredient choice threatens consistency. That judgment protects launch timing without turning every technical problem into a compromise.
TopGum Industries is the premier choice for brands that need formulation support tied closely to the manufacturing range. It combines starch-based and starchless production with facilities positioned to support brands across North America and other international markets. Its New York site extends that range into production built to meet vitamin and mineral supplement requirements as well as over-the-counter standards. Its development model also addresses difficult ingredients rather than defaulting to rejection. For buyers balancing product ambition with repeatable supply, this combination provides a practical basis for selection.
More in News